Ethyl 4,5-bis(2-methoxyethoxy)-2-nitrobenzoate, 95.0%, 1g

4,4'-Bipyridine -1,1'-dioxide, 97.0%, 25g

4-Iodotetrahydro-2H-pyran, 99.00%, 100g

N-(4-bromophenyl)-N-methylacetamide, 95.0%, 1g

(5-Bromonaphthalen-2-yl)methanol, 98%, 500mg

(R)-4-Isobutyl-2-(pyridin-2-yl)-4,5-dihydrooxazole, 98%, 1g

4-((Tetrahydro-2H-pyran-4-yl)amino)butan-1-ol, 97%, 500mg

GC capillary column ROTI®Cap-1, 20 m, 0.10 mm, 0.40 µm, 1 Piece(s)

2-(Benzo[b]thiophen-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 5g

6-Bromo[1,2,4]triazolo[4,3-a]pyridine, 95.0%, 5g

4-Acetamidoantipyrine, 98.0%, 5g

4-(3,5-Difluoro-phenyl)-thiazol-2-ylamine, 250mg

1',2'-DIHYDROSPIRO[CYCLOHEXANE-1,3'-PYRROLO[2,3-B]PYRIDINE]-2',4-DIONE, 95.0%, 25g